DrugPatentWatch Database Preview
TOSYMRA Drug Profile
» See Plans and Pricing
Which patents cover Tosymra, and what generic alternatives are available?
Tosymra is a drug marketed by Upsher Smith Labs and is included in one NDA. There are seven patents protecting this drug.
This drug has fifty patent family members in fourteen countries.
The generic ingredient in TOSYMRA is sumatriptan. There are twenty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
US ANDA Litigation and Generic Entry Outlook for Tosymra
A generic version of TOSYMRA was approved as sumatriptan by LANNETT CO INC on February 19th, 2016.
Summary for TOSYMRA
| International Patents: | 50 |
| US Patents: | 7 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TOSYMRA |
| DailyMed Link: | TOSYMRA at DailyMed |
Pharmacology for TOSYMRA
| Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
| Mechanism of Action | Serotonin 1d Receptor Agonists Serotonin 1b Receptor Agonists |
US Patents and Regulatory Information for TOSYMRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TOSYMRA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5845183 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2006025882 | Start Trial |
| European Patent Office | 2480197 | Start Trial |
| Canada | 2748268 | Start Trial |
| European Patent Office | 2381773 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
